MAYZENT

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 07de365b1dd4f2fe
Drug Approval Canada Name: MAYZENT
Product Name: MAYZENT
Status: Marketed
Status Date: 2020-04-24
Original Market Date: 2020-04-24
Din: 02496437
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.16
Atc Original: L04AE03 SIPONIMOD
Atc Name: l 04 ae 03
Aig Number: 0162037002
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

SIPONIMOD

2 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

07de365b1dd4f2fe

Type

Standard